Get the Stockscreener App
4.98
5.14%
-0.27
Anteris Technologies Global Corp stock is traded at $4.98, with a volume of 169.18K.
It is down -5.14% in the last 24 hours and up +28.02% over the past month.
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow. Company operates in USA, Germany, Australia, Switzerland, and Sweden. Majority of revenue is from USA.
See More
Previous Close:
$5.25
Open:
$5.25
24h Volume:
169.18K
Relative Volume:
0.87
Market Cap:
$205.16M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-2.5172
EPS:
-1.9784
Net Cash Flow:
-
1W Performance:
+6.64%
1M Performance:
+28.02%
6M Performance:
+2.26%
1Y Performance:
+0.00%
1-Day Range:
$4.90
$5.29
1-Week Range:
$4.54
$5.50
52-Week Range:
$2.34
$8.79
Anteris Technologies Global Corp Stock (AVR) Company Profile
Name
Anteris Technologies Global Corp
Sector
Industry
Phone
651-493-0606
Address
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
4.98 | 216.29M | 0 | 0 | 0 | -1.9784 |
|
ISRG
Intuitive Surgical Inc
|
542.32 | 194.04B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.89 | 57.21B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.80 | 38.69B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
252.27 | 36.84B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.56 | 19.61B | 2.96B | 487.70M | 344.00M | 6.6758 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Initiated | Lake Street | Buy |
| Jan-07-25 | Initiated | Barclays | Overweight |
| Jan-07-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-07-25 | Initiated | TD Cowen | Buy |
Anteris Technologies Global Corp Stock (AVR) Latest News
Anteris Technologies Begins Global PARADIGM Trial Enrollment - MSN
Anteris Technologies Issues Restricted Stock Units - TipRanks
Anteris Technologies Announces Change in Director’s Interest - TipRanks
Anteris Technologies Issues Unquoted Securities for Employee Incentives - TipRanks
FDA Approves Anteris Technologies’ DurAVR THV Global Trial - Medical Product Outsourcing
Anteris Technologies Global : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Anteris Technologies approves key proposals at annual meeting - MSN
Anteris Technologies highlights innovations at annual meeting - MSN
Anteris Technologies reports CDI adjustments for November 2025 - MSN
Anteris Technologies Global Corp Stock Analysis and ForecastCovered Call Writing & Small Budget Investment Tips - earlytimes.in
Critical Analysis: QHSLab (OTCMKTS:USAQ) and Anteris Technologies Global (NASDAQ:AVR) - Defense World
Anteris Technologies Holds Annual Stockholders Meeting - The Globe and Mail
Working capital per share of Anteris Technologies Global Corp. – ASX:AVR - TradingView
Anteris Technologies Approves Key Proposals at Annual Meeting - The Globe and Mail
Anteris Technologies Reports CDI Adjustments for November 2025 - TipRanks
How geopolitical tensions affect Anteris Technologies Global Corp. stock2025 Earnings Surprises & Daily Stock Trend Reports - Newser
Anteris Technologies Global shareholders approve board elections and equity grants - Investing.com Australia
Anteris Technologies Global shareholders approve board elections and equity grants By Investing.com - Investing.com South Africa
Why Anteris Technologies Global Corp. stock is rated strong buyJobs Report & Verified Momentum Stock Ideas - Newser
Anteris Technologies Highlights Innovations at Annual Meeting - TipRanks
Anteris Technologies Announces Cessation of Certain Securities - The Globe and Mail
Sio Capital Management LLC Decreases Stock Position in Anteris Technologies Global Corp. $AVR - MarketBeat
Anteris Technologies Announces Agreement Termination - MSN
Anteris Technologies Ends Agreement with 4C Medical - MSN
Anteris Technologies Global to end supply agreement with 4C Medical Technologies - Investing.com
Anteris Technologies ends supply deal with 4C Medical - StreetInsider
Anteris Technologies Global Corp. Not Renewing the Second Amended and Restated Supply and License Agreement - marketscreener.com
Cash per share of Anteris Technologies Global Corp. – BOATS:AVR - TradingView
Can Anteris Technologies Global Corp. stock sustain revenue growthMarket Risk Analysis & Technical Buy Zone Confirmation - BỘ NỘI VỤ
Anteris Technologies Files Form S-1 to Enhance Market Flexibility - MSN
Anteris Technologies Reports Q3 2025 Progress and Financials - MSN
Anteris Technologies Postpones Special Stockholders Meeting - MSN
Anteris Technologies Reports Positive One-Year Outcomes for DurAVR® Heart Valve - MSN
Anteris Technologies Secures A$38.5 Million for Global Expansion - MSN
Anteris Technologies Announces Cessation of Securities - MSN
Investors in Anteris Technologies Global (ASX:AVR) have unfortunately lost 75% over the last three years - Yahoo Finance
What machine learning models say about Anteris Technologies Global Corp.July 2025 Setups & Daily Stock Trend Watchlist - newser.com
Will Anteris Technologies Global Corp. see short term momentum2025 Institutional Moves & Weekly High Potential Alerts - newser.com
Can Anteris Technologies Global Corp. hit a new high this monthWeekly Trade Report & Real-Time Buy Zone Alerts - newser.com
Published on: 2025-11-19 06:30:50 - newser.com
Is Anteris Technologies Global Corp. stock oversold or undervalued2025 EndofYear Setup & Proven Capital Preservation Methods - newser.com
Will Anteris Technologies Global Corp. continue its uptrendWeekly Profit Summary & Real-Time Buy Signal Alerts - newser.com
Anteris Technologies Reports Positive DurAVR® THV Outcomes - MSN
Anteris Technologies Global Corp. stock momentum explainedJuly 2025 Final Week & Risk Managed Investment Signals - newser.com
Why Anteris Technologies Global Corp. stock is seen as undervaluedDollar Strength & Growth Focused Investment Plans - newser.com
Anteris Technologies Reports Positive 30-Day Outcomes for DurAVR® THV - MSN
Promising Potential of Anteris Technologies’ DurAVR System Justifies Buy Rating - TipRanks
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves - The Manila Times
Detecting price anomalies in Anteris Technologies Global Corp. with AI2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Anteris Technologies Advances with Stockholder Approvals and PARADIGM Trial Update - MSN
Anteris unveils strong 30-day DurAVR® data in 100-patient small-annulus cohort - Proactive financial news
Anteris Technologies Global Corp Stock (AVR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):